Latest Telithromycin Stories
Cempra Pharmaceuticals Profiles the Broad Spectrum and Potent Activity Profile of Solithromycin (CEM-101) at the 5th Annual PHEMCE Stakeholders Workshop and BARDA Industry Day
CHAPEL HILL, N.C., Jan.
Molecular Mechanisms That Could Explain Unique Adverse Events Observed in Patients Treated With the Antibiotic Telithromycin (Ketek(TM)) is Reported in Antimicrobial Agents and Chemotherapy
CHAPEL HILL, N.C., Dec.
Cempra Pharmaceuticals Presents New Data on Its Multi-Drug Resistant Anti-Infective Portfolio, Solithromycin (CEM-101) and TAKSTA(TM) (CEM-102), at The 48th Annual Meeting of The Infectious Diseases Society Of America
CHAPEL HILL, N.C., Oct.
Word of the Day
The word 'quotha' is an alteration of 'quoth he'.